Search Results - Dyson, Alftan

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    1550. Engaging Black Women on Cabotegravir LA for PrEP by Optimizing Novel Implementation Strategies (EBONI) Study: Provider Perceptions of Appropriateness of Cabotegravir LA for PrEP for Cis-and-Trans Black Women

    1550. Engaging Black Women on Cabotegravir LA for PrEP by Optimizing Novel Implementation Strategies (EBONI) Study: Provider Perceptions of Appropriateness of Cabotegravir LA for P... by Richmond, Teriya, Dunn, Michael, Bernard, Marye, Urbaityte, Rimgaile, Sutton, Kenneth, Sutherland-Phillips, Denise, Dyson, Alftan, Merrill, Deanna, Chang, Samantha, Mack, Nicole, Haley, Amber, Brown, Kimberley, Evans, Tammeka

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    365. Durable efficacy and robust CD4+ T-cell count improvement observed across age, race, sex, and geographic subgroups of heavily treatment-experienced people with multidrug-resistant HIV-1 after 240 weeks of fostemsavir treatment

    365. Durable efficacy and robust CD4+ T-cell count improvement observed across age, race, sex, and geographic subgroups of heavily treatment-experienced people with multidrug-resis... by Dyson, Alftan, Aberg, Judith A, Molina, Jean-Michel, Cassetti, Isabel, Kozal, Michael, Treviño-Pérez, Sandra, Latiff, Gulam, Lalezari, Jacob, Pialoux, Gilles, Li, Bo, Prakash, Manyu, Clark, Andrew, Tenorio, Allan R, Pierce, Amy, Lataillade, Max

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: